Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00464685 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of a New Treatment in Combination With Laser for Diabetic Macular Edema
A Phase 2 study, sponsored by Allergan.
- Completed
- Registry status
- Phase 2
- Development phase
- 253
- Enrollment target
NCT00464685 is a Phase 2 study that has completed, run by Allergan. The registered enrollment target is 253 participants.
The verdict
NCT00464685, a Phase 2 study, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 253 participants
- Enrollment target
Study Summary
This study will evaluate the safety and efficacy of the intravitreal implant of dexamethasone with laser treatment vs. laser treatment alone in patients with diabetic macular edema.
Interventions
- DRUG Dexamethasone
- DRUG Sham injection
- PROCEDURE Laser Photocoagulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 253 participants |
| Start Date | 2007-05-01 |
| Est. Completion | 2010-02-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00464685
The ClinicalTrials.gov registry entry for NCT00464685 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 253 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Dexamethasone is the first listed.
NCT00464685 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00464685 about?
NCT00464685 is a clinical study titled "Safety and Efficacy of a New Treatment in Combination With Laser for Diabetic Macular Edema". This study will evaluate the safety and efficacy of the intravitreal implant of dexamethasone with laser treatment vs. laser treatment alone in patients with diabetic macular edema.
What is the current status of trial NCT00464685?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 253 participants. The study started on 2007-05-01. Estimated completion is 2010-02-08.
What interventions are being tested in trial NCT00464685?
The interventions under investigation include: Dexamethasone (DRUG), Sham injection (DRUG), Laser Photocoagulation (PROCEDURE).
Who is sponsoring clinical trial NCT00464685?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.